Clinical Trial Update: A Study of Peripheral Blood Progenitor Cell (PBPC) Mobilisation by Chemotherapy With Pegfilgrastim or Filgrastim in Subjects With Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating PBPC mobilization with chemotherapy followed by pegfilgrastim or filgrastim in subjects with Non-Hodgkin lymphoma; the trial is complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• NEULASTA (pegfilgrastim)
• Neupogen (Filgrastim)

Snippet

Sponsor: Amgen | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED